There are potentially overlaps in susceptibility genes and mechanisms of disease between SD and multiple sclerosis (MS) with the JAK-STAT signalling pathways playing a role in both, leading researchers to suggest JAK-STAT inhibitors as potential therapies for both MS and SD [304]. The gene discussed is SOAT1; the disease is myeloid sarcoma.